{
    "xml": "<topic id=\"PHP195\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/acetylcysteine\" basename=\"acetylcysteine\" title=\"ACETYLCYSTEINE\">\n<title>ACETYLCYSTEINE</title>\n<body>\n<data name=\"vtmid\">77731008</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_692423180\" title=\"Chelators and antidotes\">Chelators and antidotes</xref>\n</data>\n</data>\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_627310713\" title=\"Mucolytics\">Mucolytics</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP63484\" outputclass=\"indicationsAndDose\" rev=\"1.37\" parent=\"/drugs/acetylcysteine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Tear deficiency</p>\n<p outputclass=\"therapeuticIndication\">Impaired or abnormal mucus production</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the eye</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply 3&#8211;4 times a day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Paracetamol overdosage</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child (body-weight up to 20 kg)</p>\n<p>Initially 150&#8239;mg/kg over 1 hour, dose to be administered in 3&#8239;mL/kg glucose 5%, followed by 50&#8239;mg/kg over 4 hours, dose to be administered in 7&#8239;mL/kg glucose 5%, then 100&#8239;mg/kg over 16 hours, dose to be administered in 14&#8239;mL/kg glucose 5%.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child (body-weight 20&#8211;39 kg)</p>\n<p>Initially 150&#8239;mg/kg over 1 hour, dose to be administered in 100&#8239;mL glucose 5%, followed by 50&#8239;mg/kg over 4 hours, dose to be administered in 250&#8239;mL glucose 5%, then 100&#8239;mg/kg over 16 hours, dose to be administered in 500&#8239;mL glucose 5%.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child (body-weight 40 kg and above)</p>\n<p>150&#8239;mg/kg over 1 hour, dose to be administered in 200&#8239;mL Glucose Intravenous Infusion 5%, then 50&#8239;mg/kg over 4 hours, to be started immediately after completion of first infusion, dose to be administered in 500&#8239;mL Glucose Intravenous Infusion 5%, then 100&#8239;mg/kg over 16 hours, to be started immediately after completion of second infusion, dose to be administered in 1 litre Glucose Intravenous Infusion 5%.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 40 kg and above)</p>\n<p>150&#8239;mg/kg over 1 hour, dose to be administered in 200&#8239;mL Glucose Intravenous Infusion 5%, then 50&#8239;mg/kg over 4 hours, to be started immediately after completion of first infusion, dose to be administered in 500&#8239;mL Glucose Intravenous Infusion 5%, then 100&#8239;mg/kg over 16 hours, to be started immediately after completion of second infusion, dose to be administered in 1 litre Glucose Intravenous Infusion 5%.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63255\" outputclass=\"unlicensedUse\" rev=\"1.12\" parent=\"/drugs/acetylcysteine\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>Not licensed for use in meconium ileus or for distal intestinal obstructive syndrome in children with cystic fibrosis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63641\" outputclass=\"cautions\" rev=\"1.14\" parent=\"/drugs/acetylcysteine\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<sectiondiv outputclass=\"additionalCautions\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"caution\">asthma (see Side-effects for management of asthma but do not delay acetylcysteine treatment)</ph>; <ph outputclass=\"caution\">atopy</ph>; <ph outputclass=\"caution\">may slightly increase INR</ph>; <ph outputclass=\"caution\">may slightly increase prothrombin time</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With oral use</p>\n<p>\n<ph outputclass=\"caution\">asthma</ph> (in children); <ph outputclass=\"caution\">history of peptic ulceration</ph> (in children)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63301\" outputclass=\"sideEffects\" rev=\"1.16\" parent=\"/drugs/acetylcysteine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"specificSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">hypersensitivity-like reactions</ph>; <ph outputclass=\"sideEffect\">rashes</ph>; <ph outputclass=\"sideEffect\">slight increase in INR and prothrombin time</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With oral use</p>\n<p>\n<ph outputclass=\"sideEffect\">anaphylaxis</ph> (in children); <ph outputclass=\"sideEffect\">hypersensitivity-like reactions</ph>; <ph outputclass=\"sideEffect\">rashes</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p outputclass=\"title\">Hypersensitivity-like reactions</p>\n<p>Hypersensitivity-like reactions managed by reducing infusion rate or suspending until reaction settled (rash also managed by giving antihistamine; acute asthma managed by giving nebulised shortacting beta<sub>2</sub>agonist)&#8212;contact the National Poisons Information Service if reaction severe.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63675\" outputclass=\"directionsForAdministration\" rev=\"1.23\" parent=\"/drugs/acetylcysteine\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>For <i>oral </i>administration, use oral granules, <i>or</i> dilute injection solution (200&#8239;mg/mL) to a concentration of 50&#8239;mg/mL; orange or blackcurrant juice or cola drink may be used as a diluent to mask the bitter taste.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>Glucose 5% is preferred fluid; Sodium Chloride 0.9% is an alternative if Glucose 5% unsuitable.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i> (<i>Parvolex</i>\n<tm tmtype=\"reg\"/>), give continuously in Glucose 5% or Sodium chloride 0.9%. Glucose Intravenous Infusion 5% is the preferred fluid; Sodium Chloride Intravenous Infusion 0.9% is an alternative if Glucose Intravenous Infusion 5% is unsuitable.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP195-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/acetylcysteine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: granules, tablet, eye drops, effervescent tablet, oral solution, capsule, liquid</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77940\" title=\"Tablet\" namespace=\"/drugs/acetylcysteine/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75308\" title=\"Effervescent tablet\" namespace=\"/drugs/acetylcysteine/effervescent-tablet\">Effervescent tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77109\" title=\"Capsule\" namespace=\"/drugs/acetylcysteine/capsule\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77279\" title=\"Granules\" namespace=\"/drugs/acetylcysteine/granules\">Granules</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76331\" title=\"Solution for infusion\" namespace=\"/drugs/acetylcysteine/solution-for-infusion\">Solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76059\" title=\"Eye drops\" namespace=\"/drugs/acetylcysteine/eye-drops\">Eye drops</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"2\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78164\" namespace=\"/treatment-summaries/dry-eye\" title=\"Dry eye\" count=\"1\" rel=\"backlink\">Dry eye</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78558\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\" title=\"Emergency treatment of poisoning\" count=\"12\" rel=\"backlink\">Emergency treatment of poisoning</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77940\" namespace=\"/drugs/acetylcysteine/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75308\" namespace=\"/drugs/acetylcysteine/effervescent-tablet\" title=\"Effervescent tablet\" count=\"1\" rel=\"link\">Effervescent tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77109\" namespace=\"/drugs/acetylcysteine/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77279\" namespace=\"/drugs/acetylcysteine/granules\" title=\"Granules\" count=\"1\" rel=\"link\">Granules</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76331\" namespace=\"/drugs/acetylcysteine/solution-for-infusion\" title=\"Solution for infusion\" count=\"1\" rel=\"link\">Solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76059\" namespace=\"/drugs/acetylcysteine/eye-drops\" title=\"Eye drops\" count=\"1\" rel=\"link\">Eye drops</xref>\n</links>\n</topic>",
    "id": "PHP195",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/acetylcysteine",
    "basename": "acetylcysteine",
    "title": "ACETYLCYSTEINE",
    "vtmid": "77731008",
    "drugClassification": [
        "Chelators and antidotes",
        "Mucolytics"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Tear deficiency",
                        "html": "Tear deficiency"
                    },
                    {
                        "textContent": "Impaired or abnormal mucus production",
                        "html": "Impaired or abnormal mucus production"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the eye"
                    ],
                    "textContent": "To the eye",
                    "html": "To the eye"
                },
                "adult": [
                    {
                        "textContent": "Apply 3&#8211;4 times a day.",
                        "html": "<p>Apply 3&#8211;4 times a day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Paracetamol overdosage",
                        "html": "Paracetamol overdosage"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "Initially 150 mg/kg over 1 hour, dose to be administered in 3 mL/kg glucose 5%, followed by 50 mg/kg over 4 hours, dose to be administered in 7 mL/kg glucose 5%, then 100 mg/kg over 16 hours, dose to be administered in 14 mL/kg glucose 5%.",
                        "html": "<p>Initially 150&#8239;mg/kg over 1 hour, dose to be administered in 3&#8239;mL/kg glucose 5%, followed by 50&#8239;mg/kg over 4 hours, dose to be administered in 7&#8239;mL/kg glucose 5%, then 100&#8239;mg/kg over 16 hours, dose to be administered in 14&#8239;mL/kg glucose 5%.</p>",
                        "ageGroup": "(body-weight up to 20 kg)"
                    },
                    {
                        "textContent": "Initially 150 mg/kg over 1 hour, dose to be administered in 100 mL glucose 5%, followed by 50 mg/kg over 4 hours, dose to be administered in 250 mL glucose 5%, then 100 mg/kg over 16 hours, dose to be administered in 500 mL glucose 5%.",
                        "html": "<p>Initially 150&#8239;mg/kg over 1 hour, dose to be administered in 100&#8239;mL glucose 5%, followed by 50&#8239;mg/kg over 4 hours, dose to be administered in 250&#8239;mL glucose 5%, then 100&#8239;mg/kg over 16 hours, dose to be administered in 500&#8239;mL glucose 5%.</p>",
                        "ageGroup": "(body-weight 20&#8211;39 kg)"
                    },
                    {
                        "textContent": "150 mg/kg over 1 hour, dose to be administered in 200 mL Glucose Intravenous Infusion 5%, then 50 mg/kg over 4 hours, to be started immediately after completion of first infusion, dose to be administered in 500 mL Glucose Intravenous Infusion 5%, then 100 mg/kg over 16 hours, to be started immediately after completion of second infusion, dose to be administered in 1 litre Glucose Intravenous Infusion 5%.",
                        "html": "<p>150&#8239;mg/kg over 1 hour, dose to be administered in 200&#8239;mL Glucose Intravenous Infusion 5%, then 50&#8239;mg/kg over 4 hours, to be started immediately after completion of first infusion, dose to be administered in 500&#8239;mL Glucose Intravenous Infusion 5%, then 100&#8239;mg/kg over 16 hours, to be started immediately after completion of second infusion, dose to be administered in 1 litre Glucose Intravenous Infusion 5%.</p>",
                        "ageGroup": "(body-weight 40 kg and above)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "150 mg/kg over 1 hour, dose to be administered in 200 mL Glucose Intravenous Infusion 5%, then 50 mg/kg over 4 hours, to be started immediately after completion of first infusion, dose to be administered in 500 mL Glucose Intravenous Infusion 5%, then 100 mg/kg over 16 hours, to be started immediately after completion of second infusion, dose to be administered in 1 litre Glucose Intravenous Infusion 5%.",
                        "html": "<p>150&#8239;mg/kg over 1 hour, dose to be administered in 200&#8239;mL Glucose Intravenous Infusion 5%, then 50&#8239;mg/kg over 4 hours, to be started immediately after completion of first infusion, dose to be administered in 500&#8239;mL Glucose Intravenous Infusion 5%, then 100&#8239;mg/kg over 16 hours, to be started immediately after completion of second infusion, dose to be administered in 1 litre Glucose Intravenous Infusion 5%.</p>",
                        "ageGroup": "(body-weight 40 kg and above)"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Not licensed for use in meconium ileus or for distal intestinal obstructive syndrome in children with cystic fibrosis.",
                "html": "<p>Not licensed for use in meconium ileus or for distal intestinal obstructive syndrome in children with cystic fibrosis.</p>"
            }
        ]
    },
    "cautions": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "asthma (see Side-effects for management of asthma but do not delay acetylcysteine treatment)",
                "html": "asthma (see Side-effects for management of asthma but do not delay acetylcysteine treatment)",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "atopy",
                "html": "atopy",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "may slightly increase INR",
                "html": "may slightly increase INR",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "may slightly increase prothrombin time",
                "html": "may slightly increase prothrombin time",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "asthma in children",
                "html": "asthma in children",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ],
                    "patientType": "children"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history of peptic ulceration in children",
                "html": "history of peptic ulceration in children",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ],
                    "patientType": "children"
                }
            }
        ]
    },
    "sideEffects": {
        "specific": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hypersensitivity-like reactions",
                        "html": "hypersensitivity-like reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "rashes",
                        "html": "rashes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "slight increase in INR and prothrombin time",
                        "html": "slight increase in INR and prothrombin time",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "anaphylaxis in children",
                        "html": "anaphylaxis in children",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ],
                            "patientType": "children"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hypersensitivity-like reactions",
                        "html": "hypersensitivity-like reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "rashes",
                        "html": "rashes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "title": "Hypersensitivity-like reactions",
                "textContent": "Hypersensitivity-like reactions managed by reducing infusion rate or suspending until reaction settled (rash also managed by giving antihistamine; acute asthma managed by giving nebulised shortacting beta2agonist)&#8212;contact the National Poisons Information Service if reaction severe.",
                "html": "<p>Hypersensitivity-like reactions managed by reducing infusion rate or suspending until reaction settled (rash also managed by giving antihistamine; acute asthma managed by giving nebulised shortacting beta<sub>2</sub>agonist)&#8212;contact the National Poisons Information Service if reaction severe.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "For oral administration, use oral granules, or dilute injection solution (200 mg/mL) to a concentration of 50 mg/mL; orange or blackcurrant juice or cola drink may be used as a diluent to mask the bitter taste.",
                "html": "<p>For <i>oral </i>administration, use oral granules, <i>or</i> dilute injection solution (200&#8239;mg/mL) to a concentration of 50&#8239;mg/mL; orange or blackcurrant juice or cola drink may be used as a diluent to mask the bitter taste.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Glucose 5% is preferred fluid; Sodium Chloride 0.9% is an alternative if Glucose 5% unsuitable.",
                "html": "<p>Glucose 5% is preferred fluid; Sodium Chloride 0.9% is an alternative if Glucose 5% unsuitable.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Parvolex ), give continuously in Glucose 5% or Sodium chloride 0.9%. Glucose Intravenous Infusion 5% is the preferred fluid; Sodium Chloride Intravenous Infusion 0.9% is an alternative if Glucose Intravenous Infusion 5% is unsuitable.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Parvolex</i>\n<tm tmtype=\"reg\"/>), give continuously in Glucose 5% or Sodium chloride 0.9%. Glucose Intravenous Infusion 5% is the preferred fluid; Sodium Chloride Intravenous Infusion 0.9% is an alternative if Glucose Intravenous Infusion 5% is unsuitable.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "granules",
                "tablet",
                "eye drops",
                "effervescent tablet",
                "oral solution",
                "capsule",
                "liquid"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77940",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75308",
                "label": "Effervescent tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77109",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77279",
                "label": "Granules",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76331",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76059",
                "label": "Eye drops",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78164",
                "label": "Dry eye",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78558",
                "label": "Emergency treatment of poisoning",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77940",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75308",
                "label": "Effervescent tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77109",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77279",
                "label": "Granules",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76331",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76059",
                "label": "Eye drops",
                "type": "medicinalForm"
            }
        ]
    }
}